Neubase Therapeutics Inc Stock Forecast
Neubase Therapeutics Inc stock price up 0.0962% on Wednesday
(Updated on May 01, 2024)
The Neubase Therapeutics Inc stock price gained 0.0962% on the last trading day (Wednesday, 1st May 2024), rising from $0.416 to $0.416. During the last trading day the stock fluctuated 0% from a day low at $0.416 to a day high of $0.416. The price has fallen in 5 of the last 10 days and is down by -0.93% for this period. Volume fell on the last day by -8 thousand shares and in total, 1 thousand shares were bought and sold for approximately $487.55 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.71% during the next 3 months and, with a 90% probability hold a price between $0.180 and $0.558 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NBSE Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 09, 2024, and so far it has risen 5.32%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neubase Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.425 and $0.572. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Neubase Therapeutics Inc stock
Neubase Therapeutics Inc finds support from accumulated volume at $0.402 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.14%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NBSE) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Neubase Therapeutics Inc to open at $0.416, and during the day (based on 14 day Average True Range), to move between $0.373 and $0.459, which gives a possible trading interval of +/-$0.0435 (+/-10.45%) up or down from last closing price. If Neubase Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 20.91% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.402 (3.37%) than the resistance at $0.435 (4.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Neubase Therapeutics Inc will release earnings BMO on Thursday, May 09, 2024. We will update the financials statements for Neubase Therapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.41% in the first trading day after earnings release.
Is Neubase Therapeutics Inc stock A Buy?
Neubase Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -2.231 Sell Candidate Unchanged
Predicted Opening Price for Neubase Therapeutics Inc of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $0.416 ( 0%) | $0.416 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NBSE
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.416 | . | |
| R2 | 0.416 | . | ||
| R1 | 0.416 | . | ||
| Current price: | 0.416 | |||
| Support | S1 | 0.416 | . | |
| S2 | 0.416 | . | ||
| S3 | 0.416 | . |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.479 | 15.10 % | |
| R2 | 0.450 | 8.15 % | ||
| R1 | 0.435 | 4.50 % | ||
| Current price | 0.416 | |||
| Support | S1 | 0.402 | -3.37% | |
| S2 | 0.401 | -3.56% | ||
| S3 | 0.400 | -3.77% |
FAQ
Click here for our free guide on how to buy Neubase Therapeutics Inc Stock.
